Role of Nrf2 in retinal vascular development and the vaso-obliterative phase of oxygen-induced retinopathy

In the initial stage of retinopathy of prematurity (ROP), hyperoxia causes retinal blood vessel obliteration. This is thought to occur in part through oxidative stress-induced apoptosis of endothelial cells. This study was designed to determine what role NF-E2-related factor 2 (Nrf2) plays in this p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental eye research 2010-04, Vol.90 (4), p.493-500
Hauptverfasser: Uno, Koichi, Prow, Tarl W., Bhutto, Imran A., Yerrapureddy, Adi, McLeod, D. Scott, Yamamoto, Masayuki, Reddy, Sekhar P., Lutty, Gerard A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 500
container_issue 4
container_start_page 493
container_title Experimental eye research
container_volume 90
creator Uno, Koichi
Prow, Tarl W.
Bhutto, Imran A.
Yerrapureddy, Adi
McLeod, D. Scott
Yamamoto, Masayuki
Reddy, Sekhar P.
Lutty, Gerard A.
description In the initial stage of retinopathy of prematurity (ROP), hyperoxia causes retinal blood vessel obliteration. This is thought to occur in part through oxidative stress-induced apoptosis of endothelial cells. This study was designed to determine what role NF-E2-related factor 2 (Nrf2) plays in this process. Nrf2 is a transcription factor of the anti-oxidant response element that, if induced, may protect the retina from hyperoxia-induced oxidative stress. Nrf2 knockout mice (Nrf2−/−), Nrf2 wild type control mice (Nrf2+/+), and C57BL/6 mice were exposed to hyperoxia (75% O 2) or normoxia from P7 through P12. Mice were sacrificed on P9 and P12 and the retinas were stained with GSA lectin-Cy3 to visualize retinal blood vessels. Hyperoxia exposed retinas were flat mounted and photographed, then the size of the avascular areas was determined. Additionally, retinas were cryopreserved after lectin staining and area analysis and then sectioned. Secondary or deep capillaries were then hand-counted in sections. In hyperoxia-treated mice, the avascular areas in Nrf2−/− P9 mice were significantly larger than those in Nrf2+/+ P9 mice ( P = 0.01). However, there was no significant difference between Nrf2−/− and Nrf2+/+ mice at P12. Avascular areas at P12 were significantly smaller than that at P9 in Nrf2−/−, Nrf2+/+, and C57BL/6 mice ( P = 0.0011, P = 0.009, and P = 0.001 respectively). The numbers of deep or secondary capillaries in air-reared Nrf2−/− mice were significantly decreased, when compared to Nrf2+/+ mice at P9 ( P = 0.0082). On the other hand, there was no significant difference in deep capillary formation between air-reared Nrf2−/− and Nrf2+/+ mice at P12. Akt signaling activates Nrf2 and Akt was localized to retinal blood vessels in all animals and was increased in Nrf2+/+ and Nrf2−/− mice exposed to hyperoxia as compared to normoxia mice. Interestingly, during normal development this protection by Nrf2 occurs in a specific window of time that is also shared by angiogenesis. Hyperoxia treatment revealed a similar window of time where Nrf2 regulated anti-oxidant production was beneficial and contributed to the endothelial survival.
doi_str_mv 10.1016/j.exer.2009.12.012
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4917303</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014483510000047</els_id><sourcerecordid>1093459270</sourcerecordid><originalsourceid>FETCH-LOGICAL-c553t-d353f010ebab17c9f7f5b24dfd05a43a5fe747e46e601431f12caad62b3d8b263</originalsourceid><addsrcrecordid>eNp9kV9rFDEUxYModlv9Aj5IHn2ZMX9nOiCClFqFoiD6HDLJTTdLNhmTmaH77c26teiLT4Hcc365OQehV5S0lNDu7a6Fe8gtI2RoKWsJZU_QhpKhawgh_VO0IYSKRlxyeYbOS9nVWy568RydVUsnJBk2aPctBcDJ4S_ZMewjzjD7qANedTFL0BlbWCGkaQ9xxjpaPG_hOExNGoOfIevZr4CnrS6_Oen-cAex8dEuBuwJlyY9bw8v0DOnQ4GXD-cF-vHx-vvVp-b2683nqw-3jZGSz43lkjtCCYx6pL0ZXO_kyIR1lkgtuJYOetGD6KCr3-PUUWa0th0bub0cWccv0PsTd1rGPVhTF886qCn7vc4HlbRX_06i36q7tCox0J4TXgFvHgA5_VygzGrvi4EQdIS0FFUj5kIOrCdVyk5Sk1MpGdzjM5SoY0lqp44lqWNJijJVS6qm138v-Gj500oVvDsJoMa0-movxkOsefoMZlY2-f_xfwG2a6ZR</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1093459270</pqid></control><display><type>article</type><title>Role of Nrf2 in retinal vascular development and the vaso-obliterative phase of oxygen-induced retinopathy</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Uno, Koichi ; Prow, Tarl W. ; Bhutto, Imran A. ; Yerrapureddy, Adi ; McLeod, D. Scott ; Yamamoto, Masayuki ; Reddy, Sekhar P. ; Lutty, Gerard A.</creator><creatorcontrib>Uno, Koichi ; Prow, Tarl W. ; Bhutto, Imran A. ; Yerrapureddy, Adi ; McLeod, D. Scott ; Yamamoto, Masayuki ; Reddy, Sekhar P. ; Lutty, Gerard A.</creatorcontrib><description>In the initial stage of retinopathy of prematurity (ROP), hyperoxia causes retinal blood vessel obliteration. This is thought to occur in part through oxidative stress-induced apoptosis of endothelial cells. This study was designed to determine what role NF-E2-related factor 2 (Nrf2) plays in this process. Nrf2 is a transcription factor of the anti-oxidant response element that, if induced, may protect the retina from hyperoxia-induced oxidative stress. Nrf2 knockout mice (Nrf2−/−), Nrf2 wild type control mice (Nrf2+/+), and C57BL/6 mice were exposed to hyperoxia (75% O 2) or normoxia from P7 through P12. Mice were sacrificed on P9 and P12 and the retinas were stained with GSA lectin-Cy3 to visualize retinal blood vessels. Hyperoxia exposed retinas were flat mounted and photographed, then the size of the avascular areas was determined. Additionally, retinas were cryopreserved after lectin staining and area analysis and then sectioned. Secondary or deep capillaries were then hand-counted in sections. In hyperoxia-treated mice, the avascular areas in Nrf2−/− P9 mice were significantly larger than those in Nrf2+/+ P9 mice ( P = 0.01). However, there was no significant difference between Nrf2−/− and Nrf2+/+ mice at P12. Avascular areas at P12 were significantly smaller than that at P9 in Nrf2−/−, Nrf2+/+, and C57BL/6 mice ( P = 0.0011, P = 0.009, and P = 0.001 respectively). The numbers of deep or secondary capillaries in air-reared Nrf2−/− mice were significantly decreased, when compared to Nrf2+/+ mice at P9 ( P = 0.0082). On the other hand, there was no significant difference in deep capillary formation between air-reared Nrf2−/− and Nrf2+/+ mice at P12. Akt signaling activates Nrf2 and Akt was localized to retinal blood vessels in all animals and was increased in Nrf2+/+ and Nrf2−/− mice exposed to hyperoxia as compared to normoxia mice. Interestingly, during normal development this protection by Nrf2 occurs in a specific window of time that is also shared by angiogenesis. Hyperoxia treatment revealed a similar window of time where Nrf2 regulated anti-oxidant production was beneficial and contributed to the endothelial survival.</description><identifier>ISSN: 0014-4835</identifier><identifier>EISSN: 1096-0007</identifier><identifier>DOI: 10.1016/j.exer.2009.12.012</identifier><identifier>PMID: 20064509</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>AKT protein ; Angiogenesis ; Animals ; Animals, Newborn ; Apoptosis ; Blood vessels ; Capillaries ; Cryopreservation ; development ; Disease Models, Animal ; Endothelial cells ; Eye ; Female ; Fluorescent Antibody Technique, Indirect ; Humans ; Hyperoxia ; Hyperoxia - metabolism ; Infant, Newborn ; Lectins ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Microscopy, Confocal ; NF-E2-Related Factor 2 - physiology ; Nrf2 ; Oxidative stress ; Oxygen - toxicity ; Reactive Oxygen Species ; Regulatory sequences ; Retina ; Retinal Artery Occlusion - metabolism ; Retinal Vein Occlusion - metabolism ; Retinal Vessels - growth &amp; development ; Retinopathy ; retinopathy of prematurity ; Retinopathy of Prematurity - etiology ; Retinopathy of Prematurity - metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; Survival ; Transcription factors</subject><ispartof>Experimental eye research, 2010-04, Vol.90 (4), p.493-500</ispartof><rights>2009</rights><rights>Copyright 2009. Published by Elsevier Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c553t-d353f010ebab17c9f7f5b24dfd05a43a5fe747e46e601431f12caad62b3d8b263</citedby><cites>FETCH-LOGICAL-c553t-d353f010ebab17c9f7f5b24dfd05a43a5fe747e46e601431f12caad62b3d8b263</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0014483510000047$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20064509$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Uno, Koichi</creatorcontrib><creatorcontrib>Prow, Tarl W.</creatorcontrib><creatorcontrib>Bhutto, Imran A.</creatorcontrib><creatorcontrib>Yerrapureddy, Adi</creatorcontrib><creatorcontrib>McLeod, D. Scott</creatorcontrib><creatorcontrib>Yamamoto, Masayuki</creatorcontrib><creatorcontrib>Reddy, Sekhar P.</creatorcontrib><creatorcontrib>Lutty, Gerard A.</creatorcontrib><title>Role of Nrf2 in retinal vascular development and the vaso-obliterative phase of oxygen-induced retinopathy</title><title>Experimental eye research</title><addtitle>Exp Eye Res</addtitle><description>In the initial stage of retinopathy of prematurity (ROP), hyperoxia causes retinal blood vessel obliteration. This is thought to occur in part through oxidative stress-induced apoptosis of endothelial cells. This study was designed to determine what role NF-E2-related factor 2 (Nrf2) plays in this process. Nrf2 is a transcription factor of the anti-oxidant response element that, if induced, may protect the retina from hyperoxia-induced oxidative stress. Nrf2 knockout mice (Nrf2−/−), Nrf2 wild type control mice (Nrf2+/+), and C57BL/6 mice were exposed to hyperoxia (75% O 2) or normoxia from P7 through P12. Mice were sacrificed on P9 and P12 and the retinas were stained with GSA lectin-Cy3 to visualize retinal blood vessels. Hyperoxia exposed retinas were flat mounted and photographed, then the size of the avascular areas was determined. Additionally, retinas were cryopreserved after lectin staining and area analysis and then sectioned. Secondary or deep capillaries were then hand-counted in sections. In hyperoxia-treated mice, the avascular areas in Nrf2−/− P9 mice were significantly larger than those in Nrf2+/+ P9 mice ( P = 0.01). However, there was no significant difference between Nrf2−/− and Nrf2+/+ mice at P12. Avascular areas at P12 were significantly smaller than that at P9 in Nrf2−/−, Nrf2+/+, and C57BL/6 mice ( P = 0.0011, P = 0.009, and P = 0.001 respectively). The numbers of deep or secondary capillaries in air-reared Nrf2−/− mice were significantly decreased, when compared to Nrf2+/+ mice at P9 ( P = 0.0082). On the other hand, there was no significant difference in deep capillary formation between air-reared Nrf2−/− and Nrf2+/+ mice at P12. Akt signaling activates Nrf2 and Akt was localized to retinal blood vessels in all animals and was increased in Nrf2+/+ and Nrf2−/− mice exposed to hyperoxia as compared to normoxia mice. Interestingly, during normal development this protection by Nrf2 occurs in a specific window of time that is also shared by angiogenesis. Hyperoxia treatment revealed a similar window of time where Nrf2 regulated anti-oxidant production was beneficial and contributed to the endothelial survival.</description><subject>AKT protein</subject><subject>Angiogenesis</subject><subject>Animals</subject><subject>Animals, Newborn</subject><subject>Apoptosis</subject><subject>Blood vessels</subject><subject>Capillaries</subject><subject>Cryopreservation</subject><subject>development</subject><subject>Disease Models, Animal</subject><subject>Endothelial cells</subject><subject>Eye</subject><subject>Female</subject><subject>Fluorescent Antibody Technique, Indirect</subject><subject>Humans</subject><subject>Hyperoxia</subject><subject>Hyperoxia - metabolism</subject><subject>Infant, Newborn</subject><subject>Lectins</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Microscopy, Confocal</subject><subject>NF-E2-Related Factor 2 - physiology</subject><subject>Nrf2</subject><subject>Oxidative stress</subject><subject>Oxygen - toxicity</subject><subject>Reactive Oxygen Species</subject><subject>Regulatory sequences</subject><subject>Retina</subject><subject>Retinal Artery Occlusion - metabolism</subject><subject>Retinal Vein Occlusion - metabolism</subject><subject>Retinal Vessels - growth &amp; development</subject><subject>Retinopathy</subject><subject>retinopathy of prematurity</subject><subject>Retinopathy of Prematurity - etiology</subject><subject>Retinopathy of Prematurity - metabolism</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>Survival</subject><subject>Transcription factors</subject><issn>0014-4835</issn><issn>1096-0007</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kV9rFDEUxYModlv9Aj5IHn2ZMX9nOiCClFqFoiD6HDLJTTdLNhmTmaH77c26teiLT4Hcc365OQehV5S0lNDu7a6Fe8gtI2RoKWsJZU_QhpKhawgh_VO0IYSKRlxyeYbOS9nVWy568RydVUsnJBk2aPctBcDJ4S_ZMewjzjD7qANedTFL0BlbWCGkaQ9xxjpaPG_hOExNGoOfIevZr4CnrS6_Oen-cAex8dEuBuwJlyY9bw8v0DOnQ4GXD-cF-vHx-vvVp-b2683nqw-3jZGSz43lkjtCCYx6pL0ZXO_kyIR1lkgtuJYOetGD6KCr3-PUUWa0th0bub0cWccv0PsTd1rGPVhTF886qCn7vc4HlbRX_06i36q7tCox0J4TXgFvHgA5_VygzGrvi4EQdIS0FFUj5kIOrCdVyk5Sk1MpGdzjM5SoY0lqp44lqWNJijJVS6qm138v-Gj500oVvDsJoMa0-movxkOsefoMZlY2-f_xfwG2a6ZR</recordid><startdate>20100401</startdate><enddate>20100401</enddate><creator>Uno, Koichi</creator><creator>Prow, Tarl W.</creator><creator>Bhutto, Imran A.</creator><creator>Yerrapureddy, Adi</creator><creator>McLeod, D. Scott</creator><creator>Yamamoto, Masayuki</creator><creator>Reddy, Sekhar P.</creator><creator>Lutty, Gerard A.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>5PM</scope></search><sort><creationdate>20100401</creationdate><title>Role of Nrf2 in retinal vascular development and the vaso-obliterative phase of oxygen-induced retinopathy</title><author>Uno, Koichi ; Prow, Tarl W. ; Bhutto, Imran A. ; Yerrapureddy, Adi ; McLeod, D. Scott ; Yamamoto, Masayuki ; Reddy, Sekhar P. ; Lutty, Gerard A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c553t-d353f010ebab17c9f7f5b24dfd05a43a5fe747e46e601431f12caad62b3d8b263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>AKT protein</topic><topic>Angiogenesis</topic><topic>Animals</topic><topic>Animals, Newborn</topic><topic>Apoptosis</topic><topic>Blood vessels</topic><topic>Capillaries</topic><topic>Cryopreservation</topic><topic>development</topic><topic>Disease Models, Animal</topic><topic>Endothelial cells</topic><topic>Eye</topic><topic>Female</topic><topic>Fluorescent Antibody Technique, Indirect</topic><topic>Humans</topic><topic>Hyperoxia</topic><topic>Hyperoxia - metabolism</topic><topic>Infant, Newborn</topic><topic>Lectins</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Microscopy, Confocal</topic><topic>NF-E2-Related Factor 2 - physiology</topic><topic>Nrf2</topic><topic>Oxidative stress</topic><topic>Oxygen - toxicity</topic><topic>Reactive Oxygen Species</topic><topic>Regulatory sequences</topic><topic>Retina</topic><topic>Retinal Artery Occlusion - metabolism</topic><topic>Retinal Vein Occlusion - metabolism</topic><topic>Retinal Vessels - growth &amp; development</topic><topic>Retinopathy</topic><topic>retinopathy of prematurity</topic><topic>Retinopathy of Prematurity - etiology</topic><topic>Retinopathy of Prematurity - metabolism</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>Survival</topic><topic>Transcription factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Uno, Koichi</creatorcontrib><creatorcontrib>Prow, Tarl W.</creatorcontrib><creatorcontrib>Bhutto, Imran A.</creatorcontrib><creatorcontrib>Yerrapureddy, Adi</creatorcontrib><creatorcontrib>McLeod, D. Scott</creatorcontrib><creatorcontrib>Yamamoto, Masayuki</creatorcontrib><creatorcontrib>Reddy, Sekhar P.</creatorcontrib><creatorcontrib>Lutty, Gerard A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Experimental eye research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Uno, Koichi</au><au>Prow, Tarl W.</au><au>Bhutto, Imran A.</au><au>Yerrapureddy, Adi</au><au>McLeod, D. Scott</au><au>Yamamoto, Masayuki</au><au>Reddy, Sekhar P.</au><au>Lutty, Gerard A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of Nrf2 in retinal vascular development and the vaso-obliterative phase of oxygen-induced retinopathy</atitle><jtitle>Experimental eye research</jtitle><addtitle>Exp Eye Res</addtitle><date>2010-04-01</date><risdate>2010</risdate><volume>90</volume><issue>4</issue><spage>493</spage><epage>500</epage><pages>493-500</pages><issn>0014-4835</issn><eissn>1096-0007</eissn><abstract>In the initial stage of retinopathy of prematurity (ROP), hyperoxia causes retinal blood vessel obliteration. This is thought to occur in part through oxidative stress-induced apoptosis of endothelial cells. This study was designed to determine what role NF-E2-related factor 2 (Nrf2) plays in this process. Nrf2 is a transcription factor of the anti-oxidant response element that, if induced, may protect the retina from hyperoxia-induced oxidative stress. Nrf2 knockout mice (Nrf2−/−), Nrf2 wild type control mice (Nrf2+/+), and C57BL/6 mice were exposed to hyperoxia (75% O 2) or normoxia from P7 through P12. Mice were sacrificed on P9 and P12 and the retinas were stained with GSA lectin-Cy3 to visualize retinal blood vessels. Hyperoxia exposed retinas were flat mounted and photographed, then the size of the avascular areas was determined. Additionally, retinas were cryopreserved after lectin staining and area analysis and then sectioned. Secondary or deep capillaries were then hand-counted in sections. In hyperoxia-treated mice, the avascular areas in Nrf2−/− P9 mice were significantly larger than those in Nrf2+/+ P9 mice ( P = 0.01). However, there was no significant difference between Nrf2−/− and Nrf2+/+ mice at P12. Avascular areas at P12 were significantly smaller than that at P9 in Nrf2−/−, Nrf2+/+, and C57BL/6 mice ( P = 0.0011, P = 0.009, and P = 0.001 respectively). The numbers of deep or secondary capillaries in air-reared Nrf2−/− mice were significantly decreased, when compared to Nrf2+/+ mice at P9 ( P = 0.0082). On the other hand, there was no significant difference in deep capillary formation between air-reared Nrf2−/− and Nrf2+/+ mice at P12. Akt signaling activates Nrf2 and Akt was localized to retinal blood vessels in all animals and was increased in Nrf2+/+ and Nrf2−/− mice exposed to hyperoxia as compared to normoxia mice. Interestingly, during normal development this protection by Nrf2 occurs in a specific window of time that is also shared by angiogenesis. Hyperoxia treatment revealed a similar window of time where Nrf2 regulated anti-oxidant production was beneficial and contributed to the endothelial survival.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>20064509</pmid><doi>10.1016/j.exer.2009.12.012</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0014-4835
ispartof Experimental eye research, 2010-04, Vol.90 (4), p.493-500
issn 0014-4835
1096-0007
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4917303
source MEDLINE; Elsevier ScienceDirect Journals
subjects AKT protein
Angiogenesis
Animals
Animals, Newborn
Apoptosis
Blood vessels
Capillaries
Cryopreservation
development
Disease Models, Animal
Endothelial cells
Eye
Female
Fluorescent Antibody Technique, Indirect
Humans
Hyperoxia
Hyperoxia - metabolism
Infant, Newborn
Lectins
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Microscopy, Confocal
NF-E2-Related Factor 2 - physiology
Nrf2
Oxidative stress
Oxygen - toxicity
Reactive Oxygen Species
Regulatory sequences
Retina
Retinal Artery Occlusion - metabolism
Retinal Vein Occlusion - metabolism
Retinal Vessels - growth & development
Retinopathy
retinopathy of prematurity
Retinopathy of Prematurity - etiology
Retinopathy of Prematurity - metabolism
Reverse Transcriptase Polymerase Chain Reaction
Survival
Transcription factors
title Role of Nrf2 in retinal vascular development and the vaso-obliterative phase of oxygen-induced retinopathy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T20%3A39%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20Nrf2%20in%20retinal%20vascular%20development%20and%20the%20vaso-obliterative%20phase%20of%20oxygen-induced%20retinopathy&rft.jtitle=Experimental%20eye%20research&rft.au=Uno,%20Koichi&rft.date=2010-04-01&rft.volume=90&rft.issue=4&rft.spage=493&rft.epage=500&rft.pages=493-500&rft.issn=0014-4835&rft.eissn=1096-0007&rft_id=info:doi/10.1016/j.exer.2009.12.012&rft_dat=%3Cproquest_pubme%3E1093459270%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1093459270&rft_id=info:pmid/20064509&rft_els_id=S0014483510000047&rfr_iscdi=true